Results 11 to 20 of about 9,182 (184)

Toxic epidermal necrolysis following a furosemide injection: a case report [PDF]

open access: yesJournal of Medical Case Reports
Background Toxic epidermal necrolysis is a life threatening adverse cutaneous reaction mostly following drug administration. It is characterized by extensive detachment of skin and mucous membranes with a more than 30% total body surface area involvement.
Clare Nakubulwa   +2 more
doaj   +2 more sources

Review of Toxic Epidermal Necrolysis [PDF]

open access: yesInternational Journal of Molecular Sciences, 2016
Toxic epidermal necrolysis (TEN) is a rare but life threatening mucocutaneous reaction to drugs or their metabolites. It is characterised by widespread keratinocyte apoptosis and sloughing of the skin, erosions of the mucous membranes, painful blistering, and severe systemic disturbance.
Victoria Harris   +2 more
openaire   +4 more sources

Multidisciplinary Treatment in Toxic Epidermal Necrolysis

open access: yesInternational Journal of Environmental Research and Public Health, 2023
Toxic epidermal necrolysis, Leyll’s syndrome (TEN), is a rare mucocutaneous blistering disease burdened with high mortality rates. The diagnosis of TEN is based on clinical symptoms and histopathological findings. In approximately 90% of cases, it is a severe adverse reaction to drugs.
Agnieszka Surowiecka   +2 more
openaire   +5 more sources

Toxic epidermal necrolysis [PDF]

open access: yesJournal of the American Academy of Dermatology, 2007
Toxic epidermal necrolysis (TEN) is an unpredictable, life-threatening drug reaction associated with a 30% mortality. Massive keratinocyte apoptosis is the hallmark of TEN. Cytotoxic T lymphocytes appear to be the main effector cells and there is experimental evidence for involvement of both the Fas-Fas ligand and perforin/granzyme pathways.
Frederick A, Pereira   +2 more
  +7 more sources

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

open access: yesMedisur
Stevens-Johnson syndrome and toxic epidermal necrolysis are severe mucocutaneous rare diseases with high morbid mortality characterized by generalized epidermal necrosis and skin detachment; They are distinguished from each other due to the extent of ...
Jeanneth Elizabeth Jami Carrera   +3 more
doaj   +1 more source

Terbinafine-induced Toxic Epidermal Necrolysis in Pregnancy: A Case Report

open access: yesJournal of Nepal Medical Association, 2023
Toxic epidermal necrolysis in pregnancy is a rare disease that can have an adverse effect on Toxic epidermal necrolysis in pregnancy is a rare disease that can have an adverse effect on pregnancy outcomes.
Ramesh Lamichhane   +3 more
doaj   +1 more source

Bronchiolitis obliterans associated with toxic epidermal necrolysis induced by infection: A case report and literature review

open access: yesFrontiers in Pediatrics, 2023
BackgroundStevens-Johnson syndrome/toxic epidermal necrolysis has a severe impact on patients' eyes, genital mucosa, and many other organs. Bronchiolitis obliterans is a rare complication of Stevens-Johnson syndrome/toxic epidermal necrolysis.Data ...
Jingwei Liu   +3 more
doaj   +1 more source

Combination of cyclosporine A and methylprednisolone to treat pediatric Stevens-Johnson syndrome/toxic epidermal necrolysis overlap syndrome

open access: yesDermatology Reports, 2023
The treatment of epidermal necrolysis in pediatric patients remains a major challenge. Cyclosporine A has emerged as a promising therapy for epidermal necrolysis in adults; however, its efficacy in children is unclear.
Shinta Trilaksmi Dewi   +8 more
doaj   +1 more source

Toxic epidermal necrolysis [PDF]

open access: yesF1000Research, 2016
Toxic epidermal necrolysis (TEN) is a rare, life-threatening drug-induced skin disease with a mortality rate of approximately 30%. The clinical hallmark of TEN is a marked skin detachment caused by extensive keratinocyte cell death associated with mucosal involvement. The exact pathogenic mechanism of TEN is still uncertain.
Hoetzenecker, Wolfram   +7 more
openaire   +4 more sources

Pembrolizumab-Induced Toxic Epidermal Necrolysis

open access: yesCase Reports in Oncology, 2022
Immunotherapy has nowadays become part of the mainstay of treatment for several cancers. In this report, we present a case of toxic epidermal necrolysis (TEN) occurring as a relatively rare complication of pembrolizumab, which is a humanized monoclonal ...
Luca Borg   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy